Pages without language links

Showing below up to 50 results in range #1 to #50.

1. 'The Bug Stops Here!’ Nipah Encephalitis; Kerala
2. 1-s2.0-S0042682207007593-main
3. A Brighton Collaboration standardized template with key considerations for a benefit/risk assessment for a soluble glycoprotein vaccine to prevent disease caused by Nipah or Hendra viruses
4. A Comparative Analysis of Statistical Methods to Estimate the Reproduction Number in Emerging Epidemics, With Implications for the Current Coronavirus Disease 2019 (COVID-19) Pandemic
5. A Novel DNAzyme-Based Fluorescent Biosensor for Detection of RNA-Containing Nipah Henipavirus
6. A Novel Model of Lethal Hendra Virus Infection in African Green Monkeys and the Effectiveness of Ribavirin Treatment
7. A comparative genomic approach to decipher the mutations associated with Nipah viral human isolates from southeast Asia
8. A large-scale behavior change intervention to prevent Nipah transmission in Bangladesh: components and costs
9. A recombinant VSV-vectored vaccine rapidly protects nonhuman primates against lethal Nipah virus disease
10. A review of the nipah virus
11. A short communication of Nipah virus outbreak in India: An urgent rising concern
12. A systematic review of case reports on mortality, modes of infection, diagnostic tests, and treatments for Nipah virus infection
13. A systematic review on Nipah virus: global molecular epidemiology and medical countermeasures development
14. Addressing the recurrent Nipah Virus outbreaks: A call for vigilance, collaboration, and preparedness
15. Advancements in Nipah virus treatment: Analysis of current progress in vaccines, antivirals, and therapeutics
16. Advancing the frontiers: Revolutionary control and prevention paradigms against Nipah virus
17. Aerosol exposure to intermediate size Nipah virus particles induces neurological disease in African green monkeys
18. An Immunoinformatic-Based In Silico Identification on the Creation of a Multiepitope-Based Vaccination Against the Nipah Virus
19. An Immunoinformatics Prediction of Novel Multi-Epitope Vaccines Candidate Against Surface Antigens of Nipah Virus
20. An Overview of Anthropogenic Actions as Drivers for Emerging and Re-Emerging Zoonotic Diseases
21. Animal Models for Henipavirus Research
22. Antibody response in symptomatic & asymptomatic Nipah virus cases from Kerala, India
23. Antivirotics based on defective interfering particles: emerging concepts and challenges
24. Assessing the feasibility of Nipah vaccine effliciency trials based on previous outbreaks in Bangladesh
25. Assessing the risk of Nipah virus establishment in Australian flying-foxes
26. Bats Without Borders: Long-Distance Movements and Implications for Disease Risk Management
27. Bats and viruses: a death-defying friendship
28. Bats as reservoirs of severe emerging infectious diseases
29. Beyond neurology: unravelling Nipah virus’s cardiovascular conundrum—an editorial
30. Beyond the Headlines: Why Henipaviruses Warrant Our Attention
31. Bot Test Page
32. Cat–wildlife interactions and zoonotic disease risk: a call for more and better community science data
33. Characterization of Nipah Virus from Outbreaks in Bangladesh, 2008–2010
34. Characterization of TheWe: Isolation and Phylogenetic Analysis of Nipah Virus from Pteropus vampyrus Bats
35. Climate Anomalies and Spillover of Bat-Borne Viral Diseases in the Asia–Pacific Region and the Arabian Peninsula
36. Clinical Epidemiology of Nipah Virus
37. Clinical Manifestations and Management
38. Clinical Medicine 2022 Vol 22, No 4: 348–52 - Review of Nipah virus encephalitis
39. Co-evolution of SARS-CoV-2 variants and host immune response trajectories underlie COVID-19 pandemic to epidemic transition
40. Combatting emerging infectious diseases from Nipah to COVID-19 in Kerala, India
41. Community willingness to participate in a Nipah vaccine trial in Bangladesh
42. Concern over Nipah virus cases amidst the COVID‐19 pandemic in India
43. Controlling Nipah virus encephalitis in Bangladesh: Policy options
44. Current progress towards prevention of Nipah and Hendra disease in humans: A scoping review of vaccine and monoclonal antibody candidates being evaluated in clinical trials
45. Designing potential siRNA molecules for silencing the gene of the nucleocapsid protein of Nipah virus: A computational investigation
46. Detection of Nipah virus in Pteropus medius in 2019 outbreak from Ernakulam district, Kerala, India
47. Detection of possible Nipah virus infection in Rousettus leschenaultii and Pipistrellus Pipistrellus bats in Maharashtra, India
48. Development of Nipah virus-specific IgM & IgG ELISA for screening human serum samples
49. Development of a culture-independent whole-genome sequencing of Nipah virus using the MinION Oxford Nanopore platform
50. Dexamethasone treatment does not alter mortality but reduces pulmonary pathology in Nipah virus-infected Syrian hamsters